Three Advantages of AI Implementation in Drug Discovery

This new age has been propelled by startups, who have invented new tools, and software to bring compounds to market more quickly, more affordably, and more effectively than before. In this article, we examine the benefits of using AI to drug discover

EU buys additional vaccine doses against monkeypox

The European Commission said it had secured over 10,000 tecovirimat vaccines against monkeypox, despite the declining number of cases in the European Union (EU)...

PAG-led API Platform acquire controlling stake in Optimus

PAG, a leading global investment firm, along with consortium partners CX Partners and Samara Capital, has acquired a controlling stake in the Optimus Group, a Hyderabad, based pharmaceutical firm, through the API platform Sekhmet Pharmaventures...

Pfizer/BioNTech seek FDA approval for new COVID boosters for children

Pfizer Inc and its German partner BioNTech sought the U.S. Food and Drug Administration's authorization for an Omicron-tailored COVID-19 vaccine booster for children aged 5 through 11 years...

Swiss pharma co invests more to expand gastro drugs output

Swiss firm Ferring Pharmaceuticals plans to invest an additional Rs 500 crore in expanding the manufacturing of gastrointestinal (GI) drugs in India over the next three years. The company has pumped Rs 500 crore into an active pharmaceutical...

Lupin gets USFDA approval for generic drug

Drug firm Lupin on Thursday said it has received approval from the US health regulator to market a generic non-steroidal anti-inflammatory drug in the American market. The company has received approval from the US Food and Drug Administration for...

Innovations in Cell and Gene Therapies Changing Modern-day Patient Care

Cell and gene therapies are going to be catalysts of paradigm shifts in the global healthcare arena. Both cell and gene therapies are overlapping fields having similar therapeutic objectives. And it targets DNA or RNA outside the body and both th...

BridgeBio Pharma, Sentynl Therapeutics get European Commission approved for MoCD medication

BridgeBio Pharma along with Sentynl Therapeutics has received marketing authorisation from the European Commission for a medication to treat a rare disease, according to a joint statement issued on Tuesday. The companies have received approval for...

U.S FDA approved Fennec's hearing loss therapy

The U.S. Food and Drug Administration has approved Fennec Pharmaceuticals Inc's intravenous therapy to prevent chemotherapy-induced hearing loss in children, according to the health regulator's website...

Centrum Marks its Entry in India

Centrum marks its entry in India under Haleon (erstwhile GlaxoSmithKline Consumer Healthcare). The company announced the launch of Centrum Multivitamin range recognising the difference in nutritional requirements by gender and age in India and...

© 2025 India Pharma Outlook. All Rights Reserved.